Please wait a minute...
浙江大学学报（医学版）
J Zhejiang Univ (Med Sci)  2018, Vol. 47 Issue (4): 435-440    DOI: 10.3785/j.issn.1008-9292.2018.08.17
    
Research progress on systemic lupus erythematosus overlapping organ-specific autoimmune diseases
WANG Xingxing1(),WANG Panpan2,YANG Xuyan1,*()
1. Department of Rheumatism and Immunology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
2. Department of Endocrinology, Chengdu University of TCM, Chengdu 610075, China
Download: HTML( 11 )   PDF(938KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Systemic lupus erythematosus (SLE) is a multiorgan-involved autoimmune disease, and it can overlap organ-specific autoimmune diseases such as autoimmune thyroid diseases, autoimmune hepatitis and inflammatory bowel disease. There may be some association between SLE and these autoimmune diseases, such as common immunological and genetic basis, but the pathogenic mechanism is still unclear. This review focuses on current knowledge regarding the prevalence and possible pathogenesis of SLE overlapping the above three autoimmune diseases.

Key words： Lupus erythematosus, systemic      Thyroiditis, autoimmune      Hepatitis, autoimmune      Colitis, ulcerative      Crohn disease      Review     
Received: 10 April 2018      Published: 04 December 2018
CLC:  R593.24+1  
Corresponding Authors: YANG Xuyan     E-mail: 21618189@zju.edu.cn;13819186380@163.com
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
WANG Xingxing
WANG Panpan
YANG Xuyan
Cite this article:

WANG Xingxing,WANG Panpan,YANG Xuyan. Research progress on systemic lupus erythematosus overlapping organ-specific autoimmune diseases. J Zhejiang Univ (Med Sci), 2018, 47(4): 435-440.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2018.08.17     OR     http://www.zjujournals.com/med/Y2018/V47/I4/435


系统性红斑狼疮合并器官特异性自身免疫性疾病的相关研究进展

系统性红斑狼疮（SLE）是一种多器官多系统累及的自身免疫性疾病，可以与器官特异性自身免疫性疾病如自身免疫性甲状腺疾病、自身免疫性肝炎、炎性肠疾病同时存在。SLE与这三种器官特异性自身免疫性疾病可能存在某种关联性，如相似的免疫学及基因背景，但其机制尚不清楚。本文就SLE合并上述三种自身免疫性疾病的可能机制、发病率和临床特征等作一综述。


关键词： 红斑狼疮, 系统性,  甲状腺炎, 自身免疫性,  肝炎, 自身免疫性,  结肠炎, 溃疡性,  克罗恩病,  综述 
[1]   ARKEMA E V, SIMARD J F. Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort[J/OL]. BMJ Open, 2015, 5(8): e008259.
[2]   MOLINELLI E , GIULIODORI K , CAMPANATI A et al. Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient:a random association?[J]. Acta Dermatovenerol Alp Pannonica Adriat, 2015, 24 (3): 55- 57
[3]   RASAEI N, SHAMS M, KAMALI-SARVESTANI E, et al. The prevalence of thyroid dysfunction in patients with systemic lupus erythematosus[J/OL]. Iran Red Crescent Med J, 2015, 17(12): e17298.
[4]   BATTAGLIOTTI C, RISPOLO K D, KARAKACHOFF M, et al. An overlap syndrome involving systemic lupus erythematosus and autoimmune hepatitis in an adolescent girl[J/OL]. Arch Argent Pediatr, 2016, 114(3): e155-e158.
[5]   YAMASHITA H , UEDA Y , KAWAGUCHI H et al. Systemic lupus erythematosus complicated by Crohn's disease:a case report and literature review[J]. BMC Gastroenterol, 2012, 12 174
doi: 10.1186/1471-230X-12-174
[6]   ROBAZZI T C , ADAN L F . Autoimmune thyroid disease in patients with rheumatic diseases[J]. Rev Bras Reumatol, 2012, 52 (3): 417- 430
[7]   ANTONELLI A , FERRARI S M , CORRADO A et al. Autoimmune thyroid disorders[J]. Autoimmun Rev, 2015, 14 (2): 174- 180
doi: 10.1016/j.autrev.2014.10.016
[8]   NAMJOU B , KELLY J A , KILPATRICK J et al. Linkage at 5q14.3-15 in multiplex systemic lupus erythematosus pedigrees stratified by autoimmune thyroid disease[J]. Arthritis Rheum, 2005, 52 (11): 3646- 3650
[9]   WU H , CANTOR R M , GRAHAMD S et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families:increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease[J]. Arthritis Rheum, 2005, 52 (8): 2396- 2402
doi: 10.1002/(ISSN)1529-0131
[10]   PHENEKOS C , VRYONIDOU A , GRITZAPIS A D et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis(Th1) and Graves' disease (Th2)[J]. Neuroimmunomodulation, 2004, 11 (4): 209- 213
doi: 10.1159/000078438
[11]   杨佳荟, 刘莉, 郭品娥 et al. 系统性红斑狼疮病人外周血Th细胞和Tc细胞IFN-γ及IL-4表达水平与疾病的关系[J]. 中国免疫学杂志, 2006, 22 (2): 186- 190
YANG Jiahui , LIU Li , GUO Pin'e et al. Measurement of intracellular interferon-γ and interleukin-4 in whole blood Th and Tc lymphocytes from patients with systemi lupus erythematosus[J]. Chinese Journal of Immunology, 2006, 22 (2): 186- 190
doi: 10.3321/j.issn:1000-484X.2006.02.022
[12]   FERRARI S M , ELIA G , VIRILI C et al. Systemic lupus erythematosus and thyroid autoimmunity[J]. Front Endocrinol(Lausanne), 2017, 8 138
doi: 10.3389/fendo.2017.00138
[13]   郭庆敏, 禚志红, 王怀立 et al. Graves病合并系统性红斑狼疮1例分析[J]. 临床儿科杂志, 2014, 32 (12): 1122- 1125
GUO Qingmin , ZHOU Zhihong , WANG Huaili et al. One case of childhood Graves' disease complicated with systemic lupus erythematosus:clinical manifestation and diagnosis[J]. Journal of Clinical Pediatrics, 2014, 32 (12): 1122- 1125
doi: 10.3969/j.issn.1000-3606.2014.12.08
[14]   LIU Y C , LIN W Y , TSAIM C et al. Systemic lupus erythematosus and thyroid disease-experience in a single medical center in Taiwan[J]. J Microbiol Immunol Infect, 2017, pii:S1684-1182 (17): 30084-1
[15]   WATAD A , MAHROUM N , WHITBY A et al. Hypothyroidism among SLE patients:Case-control study[J]. Autoimmun Rev, 2016, 15 (5): 484- 486
doi: 10.1016/j.autrev.2016.01.019
[16]   WATAD A , COHEN A D , COMANESHTER D et al. Hyperthyroidism association with SLE, lessons from real-life data-a case-control study[J]. Autoimmunity, 2016, 49 (1): 17- 20
doi: 10.3109/08916934.2015.1090985
[17]   ANTONELLI A , FALLAHI P , MOSCA M et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus[J]. Metabolism, 2010, 59 (6): 896- 900
doi: 10.1016/j.metabol.2009.10.010
[18]   MIHAILOVA D , GRIGOROVA R , VASSILEVA B et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus[J]. Adv Exp Med Biol, 1999, 455 55- 60
doi: 10.1007/978-1-4615-4857-7
[19]   PAN X F, GU J Q, SHANZ Y. Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis[J/OL]. PLoS One, 2015, 10(4): e0123291.
[20]   CATUREGLI P , DE REMIGIS A , ROSE N R . Hashimoto thyroiditis:clinical and diagnostic criteria[J]. Autoimmun Rev, 2014, 13 (4-5): 391- 397
doi: 10.1016/j.autrev.2014.01.007
[21]   PYZIK A , GRYWALSKA E , MATYJASZEK-MATUSZEK B et al. Immune disorders in Hashimoto's thyroiditis:what do we know so far?[J]. J Immunol Res, 2015, 2015 979167
[22]   LIBERAL R , KRAWITT E L , VIERLING J M et al. Cutting edge issues in autoimmune hepatitis[J]. J Autoimmun, 2016, 75 6- 19
doi: 10.1016/j.jaut.2016.07.005
[23]   USTA Y , GURAKAN F , AKCOREN Z et al. An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood[J]. World J Gastroenterol, 2007, 13 (19): 2764- 2767
doi: 10.3748/wjg.v13.i19.2764
[24]   BENTHAM J , MORRIS D L , DSC G et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus[J]. Nat Genet, 2015, 47 (12): 1457- 1464
doi: 10.1038/ng.3434
[25]   RUNYON B A , LABRECQUE D R , ANURAS S . The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature[J]. Am J Med, 1980, 69 (2): 187- 194
doi: 10.1016/0002-9343(80)90378-2
[26]   VAN HOEK B . The spectrum of liver disease in systemic lupus erythematosus[J]. Neth J Med, 1996, 48 (6): 244- 253
doi: 10.1016/0300-2977(96)00003-4
[27]   EBERT E C , HAGSPIEL K D . Gastrointestinal and hepatic manifestations of systemic lupus erythematosus[J]. J Clin Gastroenterol, 2011, 45 (5): 436- 441
doi: 10.1097/MCG.0b013e31820f81b8
[28]   BEISEL C , WEILER-NORMANN C , TEUFEL A et al. Association of autoimmune hepatitis and systemic lupus erythematodes:a case series and review of the literature[J]. World J Gastroenterol, 2014, 20 (35): 12662- 12667
doi: 10.3748/wjg.v20.i35.12662
[29]   BESSONE F , POLES N , ROMAM G . Challenge of liver disease in systemic lupus erythematosus:Clues for diagnosis and hints for pathogenesis[J]. World J Hepatol, 2014, 6 (6): 394- 409
doi: 10.4254/wjh.v6.i6.394
[30]   IRVING K S , SEN D , TAHIR H et al. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases[J]. Rheumatology(Oxford), 2007, 46 (7): 1171- 1173
doi: 10.1093/rheumatology/kem108
[31]   OLESI?SKA M , CHWALI?SKA-SADOWSKA H , WIESIK-SZEWCZYK E et al. Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies[J]. Pol Arch Med Wewn, 2010, 120 (3): 76- 81
[32]   OHIRA H , TAKIGUCHI J , RAI T et al. High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis[J]. Hepatol Res, 2004, 28 (3): 137- 139
doi: 10.1016/j.hepres.2003.11.008
[33]   GOLDBERG A C , BITTENCOURT P L , OLIVEIRA L C et al. Autoimmune hepatitis in Brazil:an overview[J]. Scand J Immunol, 2007, 66 (2-3): 208- 216
doi: 10.1111/sji.2007.66.issue-2-3
[34]   SHOR D B , DAHAN S , COMANESHTER D et al. Does inflammatory bowel disease coexist with systemic lupus erythematosus?[J]. Autoimmun Rev, 2016, 15 (11): 1034- 1037
doi: 10.1016/j.autrev.2016.07.027
[35]   KASER A , ZEISSIG S , BLUMBERG R S . Inflammatory bowel disease[J]. Annu Rev Immunol, 2010, 28 573- 621
doi: 10.1146/annurev-immunol-030409-101225
[36]   KATSANOS K H , VOULGARI P V , TSIANOSE V . Inflammatory bowel disease and lupus:a systematic review of the literature[J]. J Crohns Colitis, 2012, 6 (7): 735- 742
doi: 10.1016/j.crohns.2012.03.005
[37]   DE JAGER P L , GRAHAM R , FARWELL L et al. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus[J]. Genes Immun, 2006, 7 (4): 327- 334
doi: 10.1038/sj.gene.6364303
[38]   FERREIROS-VIDAL I , GARCIA-MEIJIDE J , CARREIRA P et al. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus[J]. Rheumatology(Oxford), 2003, 42 (4): 570- 574
doi: 10.1093/rheumatology/keg192
[39]   NITZAN O , ELIAS M , SALIBAW R . Systemic lupus erythematosus and inflammatory bowel disease[J]. Eur J Intern Med, 2006, 17 (5): 313- 318
doi: 10.1016/j.ejim.2006.02.001
[40]   BERNSTEIN C N , BLANCHARD J F , RAWSTHORNE P et al. The prevalence of extraintestinal diseases in inflammatory bowel disease:a population-based study[J]. Am J Gastroenterol, 2001, 96 (4): 1116- 1122
doi: 10.1111/j.1572-0241.2001.03756.x
[41]   RICART E , PANACCIONE R , LOFTUS E V et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease:a case-control study[J]. Inflamm Bowel Dis, 2004, 10 (3): 207- 214
doi: 10.1097/00054725-200405000-00005
[1] WANG Xiaoling, OUYANG Xumei, SUN Xiaoyi. Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 525-533.
[2] HU Caiqin, ZHU Biao. Progress on pathogenesis of progressive multifocal leukoence-phalopathy[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 534-540.
[3] SHI Ting, YE Xiujin. Roles of CCAAT enhancer binding protein α in acute myeloblastic leukemia[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 552-557.
[4] LI Gaopeng, HE Jia, WANG Qingqing. Progress on cancer associated fibroblasts in tumor immunoregulation[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 558-563.
[5] YE Jianyu, SUN Ziyu, HU Weiwei. Roles of astrocytes in cerebral infarction and related therapeutic strategies[J]. J Zhejiang Univ (Med Sci), 2018, 47(5): 493-498.
[6] ZHANG Lifeng,ZHANG Xinmei. Research progress on roles of vitamin D in endometriosis[J]. J Zhejiang Univ (Med Sci), 2018, 47(4): 413-418.
[7] HE Jiayi,ZHANG Xinmei. Research progress on oxidative stress in pathogenesis of endometriosis[J]. J Zhejiang Univ (Med Sci), 2018, 47(4): 419-425.
[8] XU Zhili,CUI Yiyi,LI Yan,GUO Yong. Research progress on nonspecific immune microenvironment in breast cancer[J]. J Zhejiang Univ (Med Sci), 2018, 47(4): 426-434.
[9] ZHANG Xiaoyan,KANG Lijun. Molecular and cell biological mechanism of olfactory adaptation in Caenorhabditis elegans[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 307-312.
[10] LI Fushan,FANG Ran,RAO Lin,MENG Feilong,ZHAO Xiaoli. Research progress on exosomes in diagnosis and treatment of cardiovascular diseases[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 320-326.
[11] WANG Wei,LIU Zhen,LIU Jun,ZHEN Ping,LI Xusheng,SONG Mingjia. Choice of total knee arthroplasty: posterior cruciate ligament preserved or not[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 313-319.
[12] QIAN Bo,ZHANG Yanling,MO Xuming. Research progress on transcription factors and signal pathways involved in congenital esophageal atresia[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 239-243.
[13] TIAN Guangfeng,GAO Hui,HU Shasha,SHU Qiang. Research progress on genetic and epigenetic mechanisms in congenital heart disease[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 227-238.
[14] CHEN Ting,ZHAO Zhengyan,JIANG Pingping,SHU Qiang. Research progress on phenotype and genotype of hyperphenylalaninemia[J]. J Zhejiang Univ (Med Sci), 2018, 47(3): 219-226.
[15] JIANG Xiyi,LI Lu,TANG Huijuan,CHEN Tianhui. Multiple risk factors prediction models for high risk population of colorectal cancer[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 194-200.